Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M Black

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Frontiers in Oncology|August 2, 2023
Corrigendum: Real-world treatment patterns and outcomes among individuals receiving first-line pembrolizumab therapy for recurrent/metastatic head and neck squamous cell carcinomaChristopher M Black, Glenn J Hanna, Liya Wang, et al.
BMJ Open Gastroenterology|November 17, 2020
Treatment persistence and colectomy-free outcomes in patients with ulcerative colitis receiving golimumab or adalimumab: a UK experienceSami Hoque, Amy Puenpatom, Simona Boccaletti, et al.
Frontiers in Oncology|June 7, 2023
Real-world treatment patterns and outcomes among individuals receiving first-line pembrolizumab therapy for recurrent/metastatic head and neck squamous cell carcinomaChristopher M Black, Glenn J Hanna, Liya Wang, et al.
Journal of Alzheimer'S Disease : JAD|May 12, 2020
Multi-National, Cross-Sectional Survey of Healthcare Resource Utilization in Patients with All Stages of Cognitive Impairment, Analyzed by Disease Severity, Country, and Geographical RegionRezaul K Khandker, Craig W Ritchie, Christopher M Black, et al.
Journal of Alzheimer'S Disease : JAD|February 15, 2018
Quantifying the Diagnostic Pathway for Patients with Cognitive Impairment: Real-World Data from Seven European and North American CountriesCraig W Ritchie, Christopher M Black, Rezaul K Khandker, et al.
Journal of Alzheimer'S Disease : JAD|May 12, 2020
Quantifying and Describing the Natural History and Costs of Alzheimer's Disease and Effects of Hypothetical InterventionsAnders Wimo, Ron Handels, Bengt Winblad, et al.
Plos One|December 7, 2018
Non-professional caregiver burden is associated with the severity of patients' cognitive impairmentChristopher M Black, Craig W Ritchie, Rezaul K Khandker, et al.
Artificial Intelligence in Medicine|January 26, 2020
Predicting dementia with routine care EMR dataZina Ben Miled, Kyle Haas, Christopher M Black, et al.
Journal of Genetic Counseling|May 29, 2023
Medicare beneficiary barriers to genetic counselor services: Implications for patient policy, decision-making, and careSara Riordan, John Richardson, Heather Zierhut, et al.
BMJ Open|May 31, 2019
Real-world treatment persistence of golimumab in the management of immune-mediated rheumatic diseases in Europe: a systematic literature reviewKarin Luttropp, Mary Dozier, Nahila Justo, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Frontiers in Oncology|August 2, 2023
Corrigendum: Real-world treatment patterns and outcomes among individuals receiving first-line pembrolizumab therapy for recurrent/metastatic head and neck squamous cell carcinomaChristopher M Black, Glenn J Hanna, Liya Wang, et al.
BMJ Open Gastroenterology|November 17, 2020
Treatment persistence and colectomy-free outcomes in patients with ulcerative colitis receiving golimumab or adalimumab: a UK experienceSami Hoque, Amy Puenpatom, Simona Boccaletti, et al.
Frontiers in Oncology|June 7, 2023
Real-world treatment patterns and outcomes among individuals receiving first-line pembrolizumab therapy for recurrent/metastatic head and neck squamous cell carcinomaChristopher M Black, Glenn J Hanna, Liya Wang, et al.
Journal of Alzheimer'S Disease : JAD|May 12, 2020
Multi-National, Cross-Sectional Survey of Healthcare Resource Utilization in Patients with All Stages of Cognitive Impairment, Analyzed by Disease Severity, Country, and Geographical RegionRezaul K Khandker, Craig W Ritchie, Christopher M Black, et al.
Journal of Alzheimer'S Disease : JAD|February 15, 2018
Quantifying the Diagnostic Pathway for Patients with Cognitive Impairment: Real-World Data from Seven European and North American CountriesCraig W Ritchie, Christopher M Black, Rezaul K Khandker, et al.
Journal of Alzheimer'S Disease : JAD|May 12, 2020
Quantifying and Describing the Natural History and Costs of Alzheimer's Disease and Effects of Hypothetical InterventionsAnders Wimo, Ron Handels, Bengt Winblad, et al.
Plos One|December 7, 2018
Non-professional caregiver burden is associated with the severity of patients' cognitive impairmentChristopher M Black, Craig W Ritchie, Rezaul K Khandker, et al.
Artificial Intelligence in Medicine|January 26, 2020
Predicting dementia with routine care EMR dataZina Ben Miled, Kyle Haas, Christopher M Black, et al.
Journal of Genetic Counseling|May 29, 2023
Medicare beneficiary barriers to genetic counselor services: Implications for patient policy, decision-making, and careSara Riordan, John Richardson, Heather Zierhut, et al.
BMJ Open|May 31, 2019
Real-world treatment persistence of golimumab in the management of immune-mediated rheumatic diseases in Europe: a systematic literature reviewKarin Luttropp, Mary Dozier, Nahila Justo, et al.
Pageof 7